account_id none on file
legal_name Atea Pharmaceuticals, Inc.
ticker AVIR
cik 1593899
domain ateapharma.com
linkedin_company_url https://www.linkedin.com/company/atea-pharmaceuticals-inc
entry_point_account_id none on file
name Atea Pharmaceuticals Inc.
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 3 filings 0 executives 3 family 0
why_nownone on file
calls
But for wealthier countries where it might be more of a traveler's market, particularly if you look at the traveler's market in the United States, a lot of travelers are reluctant to get a vaccine, particularly a series before they travel.
Nov 7, 2022 / receipt, needs a key / John, other | earnings call 2022-11-07 | transcript 994e4bc5-a1b7-43f8-8494-b45a95364c44 | chars 28828-29067 | segment 29
We saw it with hepatitis A. We saw it with others. And oral prophylactic for, you know, for prophylaxis of travel really would be the preferred there.
Nov 7, 2022 / receipt, needs a key / John, other | earnings call 2022-11-07 | transcript 994e4bc5-a1b7-43f8-8494-b45a95364c44 | chars 29068-29218 | segment 29
So, I was just saying that, and particularly for the travels-related market, an oral prophylactic would be preferred than getting a vaccination for dengue fever.
Nov 7, 2022 / receipt, needs a key / John, other | earnings call 2022-11-07 | transcript 994e4bc5-a1b7-43f8-8494-b45a95364c44 | chars 29421-29582 | segment 30
filingsnone on file
executives
| Andrea Corcoran | Chief Financial Officer and Executive Vice President of Legal | - | receipt |
| Dr. Janet Hammond | Chief Development Officer | - | receipt |
| John Zabrica | Chief Commercial Officer | - | receipt |
familynone on file
upcoming
| 2026-11-11 | earnings call | scheduled | ir |
changesnone on file
mcp_package_hint
slug atea-pharmaceuticals-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$